{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T11:58:22Z","timestamp":1793534302388,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ijrobp.2021.07.1695","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T05:01:52Z","timestamp":1627448512000},"page":"936-948","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":163,"title":["The Influence of Severe Radiation-Induced Lymphopenia on Overall Survival in Solid Tumors: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7042-7075","authenticated-orcid":false,"given":"Pim J.J.","family":"Damen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiuri E.","family":"Kroese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"van Hillegersberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewoud","family":"Schuit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost J.C.","family":"Verhoeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven H.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.N.","family":"van Rossum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0001","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2217\/cns.12.14","article-title":"Severity, etiology and possible consequences of treatment-related lymphopenia in patients with newly diagnosed high-grade gliomas","volume":"1","author":"Yovino","year":"2012","journal-title":"CNS Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0002","first-page":"139","article-title":"Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes","author":"Sellins","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0003","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1172\/JCI108084","article-title":"A comparison of the acute effects of radiation therapy, including or excluding the thymus, on the lymphocyte subpopulations of cancer patients","volume":"56","author":"Stratton","year":"1975","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0004","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature10673","article-title":"Cancer immunotherapy comes of age","volume":"480","author":"Mellman","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2016.00020","article-title":"T cells and cancer: How metabolism shapes immunity","volume":"7","author":"Molon","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0006","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cell.2018.09.035","article-title":"A paradigm shift in cancer immunotherapy: From enhancement to normalization","volume":"175","author":"Sanmamed","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0007","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1158\/0008-5472.CAN-08-3845","article-title":"Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas","volume":"69","author":"Ray-Coquard","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0008","doi-asserted-by":"crossref","first-page":"6677","DOI":"10.2147\/CMAR.S188578","article-title":"Total lymphocyte count, neutrophil\u2013lymphocyte ratio, and platelet\u2013lymphocyte ratio as prognostic factors in advanced non\u2013small cell lung cancer with chemoradiotherapy","volume":"10","author":"Song","year":"2018","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0009","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.bjc.6602934","article-title":"Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma","volume":"94","author":"Hiraoka","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0010","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1158\/1078-0432.CCR-10-2557","article-title":"Effector T-cell infiltration positively impacts survival of glioblastoma patients and is impaired by tumor-derived TGF-\u03b2","volume":"17","author":"Lohr","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0011","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1172\/JCI31405","article-title":"Immune surveillance of tumors","volume":"117","author":"Swann","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0012","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/bjc.2011.189","article-title":"The prognostic influence of tumour-infiltrating lymphocytes in cancer: A systematic review with meta-analysis","volume":"105","author":"Gooden","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0013","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.critrevonc.2018.01.003","article-title":"A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors","volume":"123","author":"Venkatesulu","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0014","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/S0167-8140(19)30462-1","article-title":"PV-0042 Radiation related lymphopenia as a predictor of locoregional recurrence in early breast cancer","volume":"133","author":"Cho","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0015","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.radonc.2018.05.017","article-title":"Cardiac dose is associated with immunosuppression and poor survival in locally advanced non-small cell lung cancer","volume":"128","author":"Contreras","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0016","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.radonc.2019.07.016","article-title":"Are unsatisfactory outcomes after concurrent chemoradiotherapy for locally advanced non-small cell lung cancer due to treatment-related immunosuppression?","volume":"143","author":"Thor","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0017","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.radonc.2019.12.023","article-title":"Lymphopenia during radiotherapy in patients with oropharyngeal cancer","volume":"145","author":"Ng","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0018","doi-asserted-by":"crossref","first-page":"23","DOI":"10.14338\/IJPT-17-00033.1","article-title":"Lymphocyte-sparing effect of proton therapy in patients with esophageal cancer treated with definitive chemoradiation","volume":"4","author":"Fang","year":"2017","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0019","doi-asserted-by":"crossref","DOI":"10.1007\/s12094-020-02345-3","article-title":"Radiation-induced lymphopenia: The main aspects to consider in immunotherapy trials for endometrial and cervical cancer patients","author":"Holub","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0020","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.ijrobp.2004.12.085","article-title":"Primary brain tumors treated with steroids and radiotherapy: Low CD4 counts and risk of infection","volume":"62","author":"Hughes","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0021","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s13566-019-00384-0","article-title":"Lymphopenia as a predictor of survival in chemoradiation-treated stage III non-small-cell lung cancer (NSCLC): A multi-center retrospective analysis","volume":"8","author":"Karivedu","year":"2019","journal-title":"J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.oraloncology.2018.08.008","article-title":"Post-operative radiation effects on lymphopenia, neutrophil to lymphocyte ratio, and clinical outcomes in palatine tonsil cancers","volume":"86","author":"Lin","year":"2018","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0023","article-title":"Proton therapy reduces the likelihood of high-grade radiation\u2013induced lymphopenia in glioblastoma patients: Phase II randomized study of protons vs photons","author":"Mohan","year":"2020","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0024","first-page":"17","article-title":"Absolute lymphocyte count in preoperative chemoradiotherapy for rectal cancer: Changes over time and prognostic significance","author":"Oh","year":"2018","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0025","first-page":"15","article-title":"Survival impact of pre-treatment neutrophils on oropharyngeal and laryngeal cancer patients undergoing definitive radiotherapy","author":"Sumner","year":"2017","journal-title":"J Transl Med"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0027","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0028","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions | Cochrane Training. Available at: https:\/\/training.cochrane.org\/handbook\/current. Accessed February 25, 2021."},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0029","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/0895-4356(95)00048-8","article-title":"Importance of events per independent variable in proportional hazards regression analysis II. Accuracy and precision of regression estimates","volume":"48","author":"Peduzzi","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0030","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13014-019-1287-z","article-title":"Treatment-duration is related to changes in peripheral lymphocyte counts during definitive radiotherapy for unresectable stage III NSCLC","volume":"14","author":"Zhao","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0031","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.jtho.2020.06.008","article-title":"Radiotherapy-related lymphopenia affects overall survival in patients with lung cancer","volume":"15","author":"Abravan","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0032","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.1016\/j.ijrobp.2019.06.142","article-title":"Impact of lymphopenia on survival following stereotactic radiosurgery and immune-checkpoint inhibitors among patients with brain metastases","volume":"105","author":"Benitez","year":"2019","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0033","doi-asserted-by":"crossref","first-page":"E206","DOI":"10.1016\/j.ijrobp.2019.06.2041","article-title":"Dose to heart, spine, aorta, and body predict for severe lymphopenia and poor survival in patients undergoing chemoradiation for esophageal cancer","volume":"105","author":"Zhang","year":"2019","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0034","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/07357907.2013.767342","article-title":"Treatment-related lymphopenia in patients with stage III non-small-cell lung cancer","volume":"31","author":"Campian","year":"2013","journal-title":"Cancer Invest"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0035","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13014-019-1256-6","article-title":"Clinical predictors of radiation-induced lymphopenia in patients receiving chemoradiation for glioblastoma: Clinical usefulness of intensity-modulated radiotherapy in the immuno-oncology era","volume":"14","author":"Byun","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0036","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11060-015-2037-1","article-title":"Association between treatment-related lymphopenia and overall survival in elderly patients with newly diagnosed glioblastoma","volume":"127","author":"Mendez","year":"2016","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0037","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ijrobp.2018.01.069","article-title":"Effect of radiation treatment volume reduction on lymphopenia in patients receiving chemoradiotherapy for glioblastoma","volume":"101","author":"Rudra","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0038","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3109\/07357907.2012.700987","article-title":"The association between treatment-related lymphopenia and survival in newly diagnosed patients with resected adenocarcinoma of the pancreas","volume":"30","author":"Balmanoukian","year":"2012","journal-title":"Cancer Invest"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0039","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijrobp.2016.10.046","article-title":"Does unintentional splenic radiation predict outcomes after pancreatic cancer radiation therapy?","volume":"97","author":"Chadha","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0040","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ijrobp.2015.11.026","article-title":"Lymphocyte-sparing effect of stereotactic body radiation therapy in patients with unresectable pancreatic cancer","volume":"94","author":"Wild","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0041","doi-asserted-by":"crossref","first-page":"e425","DOI":"10.1002\/onco.13533","article-title":"Lymphopenia during definitive chemoradiotherapy in esophageal squamous cell carcinoma: Association with dosimetric parameters and patient outcomes","volume":"26","author":"Xu","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0042","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.radonc.2018.12.002","article-title":"The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy","volume":"133","author":"Deng","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0043","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00066-019-01462-5","article-title":"Acute severe lymphopenia by radiotherapy is associated with reduced overall survival in hepatocellular carcinoma","volume":"195","author":"Byun","year":"2019","journal-title":"Strahlentherapie und Onkol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0044","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9691067","article-title":"Lymphopenia is associated with gross target volumes and fractions in hepatocellular carcinoma patients treated with external beam radiation therapy and also indicates worse overall survival","volume":"2019","author":"Zhang","year":"2019","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0045","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ygyno.2015.11.013","article-title":"Lymphopenia and its association with survival in patients with locally advanced cervical cancer","volume":"140","author":"Wu","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0046","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1097\/IGC.0000000000001345","article-title":"The utility of pretreatment and posttreatment lymphopenia in cervical squamous cell carcinoma patients treated with definitive chemoradiotherapy","volume":"28","author":"Onal","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0047","first-page":"28","article-title":"Prognostic impact of leukocyte counts before and during radiotherapy for oropharyngeal cancer","volume":"7","author":"Jensen","year":"2017","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0048","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1159\/000500461","article-title":"Irradiation-related lymphopenia for bone metastasis from hepatocellular carcinoma","volume":"8","author":"Park","year":"2019","journal-title":"Liver Cancer"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0049","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1634\/theoncologist.2019-0759","article-title":"Chemoradiation-related lymphopenia and its association with survival in patients with squamous cell carcinoma of the anal canal","volume":"25","author":"Lee","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0050","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/jamaoto.2019.0034","article-title":"Association of posttreatment lymphopenia and elevated neutrophil-to-lymphocyte ratio with poor clinical outcomes in patients with human papillomavirus-negative oropharyngeal cancers","volume":"145","author":"Lin","year":"2019","journal-title":"JAMA Otolaryngol - Head Neck Surg"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0051","first-page":"625","article-title":"Effects of chemotherapy regimen and radiation modality on hematologic toxicities in patients receiving definitive platinum-based doublet chemoradiation for non-small cell lung cancer","volume":"40","author":"Tang","year":"2017","journal-title":"Am J Clin Oncol Cancer Clin Trials"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0052","first-page":"15","article-title":"Radiotherapy-related lymphopenia in patients with advanced non-small cell lung cancer receiving palliative radiotherapy","volume":"22","author":"Abravan","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0053","doi-asserted-by":"crossref","first-page":"226","DOI":"10.5114\/wo.2019.91524","article-title":"Lymphopaenia and accidental splenic doses: Do they have any prognostic value for locally advanced gastric cancer patients treated with radiochemotherapy?","volume":"23","author":"Sert","year":"2019","journal-title":"Wspolczesna Onkol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0054","unstructured":"Cho O, Chun M, Chang SJ, Oh YT, Noh K. Prognostic value of severe lymphopenia during pelvic concurrent chemoradiotherapy in cervical cancer - PubMed. Anticancer Res. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/27354621\/. Accessed September 12, 2020."},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0055","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13014-020-01494-7","article-title":"Radiation-induced lymphopenia correlates with survival in nasopharyngeal carcinoma: Impact of treatment modality and the baseline lymphocyte count","volume":"15","author":"Xie","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0056","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.radonc.2020.02.015","article-title":"The impact of the effective dose to immune cells on lymphopenia and survival of esophageal cancer after chemoradiotherapy","volume":"146","author":"Xu","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0057","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijrobp.2017.05.037","article-title":"Lymphocyte nadir and esophageal cancer survival outcomes after chemoradiation therapy","volume":"99","author":"Davuluri","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0058","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1016\/j.prro.2019.07.010","article-title":"Prediction of severe lymphopenia during chemoradiation therapy for esophageal cancer: Development and validation of a pretreatment nomogram","volume":"10","author":"van Rossum","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0059","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.ijrobp.2015.04.005","article-title":"Clinical and dosimetric predictors of acute severe lymphopenia during radiation therapy and concurrent temozolomide for high-grade glioma","volume":"92","author":"Huang","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0060","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.radonc.2019.03.008","article-title":"Post-treatment lymphocytopaenia, integral body dose and overall survival in lung cancer patients treated with radical radiotherapy","volume":"135","author":"Joseph","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0061","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11060-019-03167-2","article-title":"Clinical observation of lymphopenia in patients with newly diagnosed glioblastoma","volume":"143","author":"Kim","year":"2019","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0062","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.radonc.2020.07.026","article-title":"Significance of lymphocyte recovery from treatment-related lymphopenia in locally advanced pancreatic cancer","volume":"151","author":"Lee","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0063","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11060-019-03146-7","article-title":"Impact of overall corticosteroid exposure during chemoradiotherapy on lymphopenia and survival of glioblastoma patients","volume":"143","author":"Hui","year":"2019","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0064","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.radonc.2017.11.028","article-title":"Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy","volume":"128","author":"Shiraishi","year":"2018","journal-title":"Radiother Oncol"},{"issue":"15_suppl","key":"10.1016\/j.ijrobp.2021.07.1695_bib0065","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1200\/jco.2015.33.15_suppl.1069","article-title":"Lymphopenia after adjuvant radiotherapy (RT) to predict poor survival in triple-negative breast cancer (TNBC)","volume":"33","author":"Afghahi","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0066","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10549-018-05106-7","article-title":"Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer","volume":"174","author":"Patel","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0067","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.adro.2020.03.021","article-title":"Lymphopenia and radiation dose to circulating lymphocytes with neoadjuvant chemoradiation in esophageal squamous cell carcinoma","volume":"5","author":"So","year":"2020","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0068","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.jtho.2017.02.018","article-title":"Long-term outcomes of salvage stereotactic ablative radiotherapy for isolated lung recurrence of non\u2013small cell lung cancer: A phase II clinical trial","volume":"12","author":"Sun","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0069","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijrobp.2020.02.633","article-title":"Radiation-induced lymphopenia predicts poorer prognosis in patients with breast cancer: A post hoc analysis of a randomized controlled trial of postmastectomy hypofractionated radiation therapy","volume":"108","author":"Sun","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0070","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s10147-020-01623-y","article-title":"Postradiotherapy persistent lymphopenia as a poor prognostic factor in patients with cervical cancer receiving radiotherapy: A single-center, retrospective study","volume":"25","author":"Taguchi","year":"2020","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0071","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2014.04.025","article-title":"Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes","volume":"89","author":"Tang","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0072","doi-asserted-by":"crossref","first-page":"E113","DOI":"10.1016\/j.ijrobp.2017.06.866","article-title":"Association between increase in WBC absolute value and survival before, during, and after concurrent chemoradiation therapy in patients with newly diagnosed glioblastoma","volume":"99","author":"Turkaj","year":"2017","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0073","doi-asserted-by":"crossref","first-page":"385","DOI":"10.21037\/atm.2019.07.58","article-title":"Lymphopenia association with accelerated hyperfractionation and its effects on limited-stage small cell lung cancer patients\u2019 clinical outcomes","volume":"7","author":"Wang","year":"2019","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0074","first-page":"259","article-title":"The association between chemoradiation-related lymphopenia and clinical outcomes in patients with locally advanced pancreatic adenocarcinoma","volume":"38","author":"Wild","year":"2015","journal-title":"Am J Clin Oncol Cancer Clin Trials"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0075","article-title":"Hematologic markers as prognostic factors in nonmetastatic esophageal cancer patients under concurrent chemoradiotherapy","volume":"2019","author":"Wu","year":"2019","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0076","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jocn.2019.11.017","article-title":"The association between total lymphocyte count after concomitant chemoradiation and overall survival in patients with newly diagnosed glioblastoma","volume":"71","author":"Ahn","year":"2020","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0077","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1002\/cam4.2159","article-title":"Dosimetry of the brain and hypothalamus predicting acute lymphopenia and the survival of glioma patients with postoperative radiotherapy","volume":"8","author":"Ye","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0078","doi-asserted-by":"crossref","first-page":"S813","DOI":"10.1016\/j.jtho.2019.08.1748","article-title":"Building and validating a lymphocyte nadir based model to predict survival in patients with limited stage-small cell lung cancer CLEPSIDRA: A phase II trial combining iadademstat with platinum-etoposide in platinum-sensitive relapsed SCLC patients","volume":"14","author":"Yu","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0079","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3389\/fonc.2019.01488","article-title":"Prognosis and risk factors of radiation-induced lymphopenia in early-stage lung cancer treated with stereotactic body radiation therapy","volume":"9","author":"Zhao","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0080","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3389\/fonc.2019.00896","article-title":"Association between circulating lymphocyte populations and outcome after stereotactic body radiation therapy in patients with hepatocellular carcinoma","volume":"9","author":"Zhuang","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0081","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1010428317734303","article-title":"Prognostic implication of simultaneous anemia and lymphopenia during concurrent chemoradiotherapy in cervical squamous cell carcinoma","volume":"39","author":"Cho","year":"2017","journal-title":"Tumor Biol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0082","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijerph17217995","article-title":"Using the systemic immune-inflammation index (SII) as a mid-treatment marker for survival among patients with stage-III locally advanced non-small cell lung cancer (NSCLC)","volume":"17","author":"Biswas","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0083","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/hed.23535","article-title":"Association between severe treatment-related lymphopenia and progression-free survival in patients with newly diagnosed squamous cell head and neck cancer","volume":"36","author":"Campian","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0084","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2020.05.051","article-title":"Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy","volume":"150","author":"Chen","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0085","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijrobp.2020.01.032","article-title":"Absolute lymphocyte count predicts abscopal responses and outcomes in patients receiving combined immunotherapy and radiation therapy: A prospective-retrospective analysis of 3 phase 1\/2 trials","volume":"108","author":"Chen","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0086","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.intimp.2019.04.032","article-title":"Prognostic value of delta inflammatory biomarker-based nomograms in patients with inoperable locally advanced NSCLC","volume":"72","author":"Guo","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0087","doi-asserted-by":"crossref","first-page":"71","DOI":"10.14791\/btrt.2020.8.e12","article-title":"Effect of cumulative dexamethasone dose during concomitant chemoradiation on lymphopenia in patients with newly diagnosed glioblastoma","volume":"8","author":"Lee","year":"2020","journal-title":"Brain Tumor Res Treat"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0088","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4143\/crt.2016.595","article-title":"The prognostic value of treatment-related lymphopenia in nasopharyngeal carcinoma patients","volume":"50","author":"Liu","year":"2018","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0100","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s13277-015-3888-y","article-title":"Radiation-related lymphopenia as a new prognostic factor in limited-stage small cell lung cancer","volume":"37","author":"Cho","year":"2016","journal-title":"Tumor Biol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0089","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13014-017-0824-x","article-title":"Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma","volume":"12","author":"Liu","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0090","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/07357907.2012.762780","volume":"31","author":"Yovino","year":"2013","journal-title":"Cancer Invest"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0091","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1667\/RR15367.1","article-title":"Comprehensive analysis of the kinetics of radiation-induced lymphocyte loss in patients treated with external beam radiation therapy","volume":"193","author":"Ellsworth","year":"2019","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0092","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.semradonc.2019.12.003","article-title":"Lymphocyte-sparing radiotherapy: The rationale for protecting lymphocyte-rich organs when combining radiotherapy with immunotherapy","volume":"30","author":"Lambin","year":"2020","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0093","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.adro.2018.09.004","article-title":"A comparison of grade 4 lymphopenia with proton versus photon radiation therapy for esophageal cancer","volume":"4","author":"Routman","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0094","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-015-1841-y","article-title":"Pre-radiation lymphocyte harvesting and post-radiation reinfusion in patients with newly diagnosed high grade gliomas","volume":"124","author":"Campian","year":"2015","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0095","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nri2970","article-title":"Harnessing the biology of IL-7 for therapeutic application","volume":"11","author":"MacKall","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0096","doi-asserted-by":"crossref","first-page":"7205","DOI":"10.1158\/0008-5472.CAN-14-1913","article-title":"Chemoradiotherapy-induced upregulation of PD-1 antagonizes immunity to HPV-related oropharyngeal cancer","volume":"74","author":"Parikh","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0097","doi-asserted-by":"crossref","first-page":"114268","DOI":"10.18632\/oncotarget.23217","article-title":"Relationships between lymphocyte counts and treatmentrelated toxicities and clinical responses in patients with solid tumors treated with PD-1 checkpoint inhibitors","volume":"8","author":"Diehl","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0098","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ijrobp.2019.08.047","article-title":"Impact of treatment-related lymphopenia on immunotherapy for advanced non-small cell lung cancer","volume":"105","author":"Cho","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.07.1695_bib0099","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijrobp.2018.09.010","article-title":"The impact of radiation therapy on lymphocyte count and survival in metastatic cancer patients receiving PD-1 immune checkpoint inhibitors","volume":"103","author":"Pike","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301621025979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301621025979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:54:24Z","timestamp":1759744464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301621025979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":100,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0360301621025979"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2021.07.1695","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Influence of Severe Radiation-Induced Lymphopenia on Overall Survival in Solid Tumors: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2021.07.1695","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}